drugset / Trial / NCT05099835

Ultrasound-Guided Stellate Ganglion Block With Botulinum

NCT05099835

Completed 60 enrolled Assiut University
RandomizedParallel-groupTriple-blindTreatment

Summary

the local stellate ganglion block with bupivacaine and corticosteroid treatment for acute peripheral facial nerve palsy in patients can induce hyperglycemia, and an alternative local therapy may be necessary and some time may ve ineffective. Our purpose in this study is to evaluate therapeutic effects of stellate ganglion block (SGB) Botulinum Toxin on referactory facial nerve palsy

Timeline

Start
2021-11-01
Primary completion
2022-06-01
Completion
2022-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 100 iu
Comparator triamcinolonacetonide Unknown 4 mg/ml Other
Comparator Bupivacaine Other / unclassified 0.1 %
Comparator Bupivacaine Other / unclassified 10 ml

Indications

No indication recorded.